Back to Journals » OncoTargets and Therapy » Volume 8
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
RETRACTED ARTICLE: Knockdown of immature colon carcinoma transcript-1 inhibits proliferation of glioblastoma multiforme cells through Gap 2/mitotic phase arrest
Authors Xie R, Zhang Y, Shen C, Cao X, Gu S, Che X
Received 15 October 2014
Accepted for publication 18 December 2014
Published 19 May 2015 Volume 2015:8 Pages 1119—1127
DOI https://doi.org/10.2147/OTT.S75864
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jianmin Xu
This paper has been retracted.
Xie R, Zhang Y, Shen C, Cao X, Gu S, Che X. Onco Targets Ther. 2015;8:1119–1127.
We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.